31 filings
Page 2 of 2
8-K
xpt7c3x7w6r3olnr
1 Aug 19
Eidos Therapeutics Reports Second Quarter 2019 Financial Results
4:31pm
8-K
5duut3
17 Jun 19
Departure of Directors or Certain Officers
4:03pm
8-K
mgzpw
7 May 19
Eidos Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
8-K
geh6jxf3q
15 Apr 19
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
8:30am
8-K
2x6do 42ju8rjuaa6h
1 Apr 19
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:06pm
8-K
pvhxdewgy2oypy15q
27 Feb 19
Other Events
7:00am
8-K
q76bfjy
21 Feb 19
Changes in Registrant's Certifying Accountant
9:00am
8-K
drr osvjqtsh
6 Dec 18
Eidos Therapeutics Appoints William Lis to Board of Directors
4:15pm
8-K
1yu2r
13 Nov 18
Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy
6:05am
8-K
8y1eclx
6 Nov 18
Results of Operations and Financial Condition
4:30pm
8-K
d4ynru79iixh2u
7 Aug 18
Results of Operations and Financial Condition
12:00am